Fifth Nitrosamine Implementation Oversight Group (NIOG) – meeting with pharmaceutical industry
Date:
12/07/2023
Location:
Online
The Nitrosamine Implementation Oversight Group (NIOG) was set up by the European medicines regulatory network to oversee the harmonised implementation of the Article 5(3) CHMP opinion on nitrosamines in human medicinal products.
The NIOG will be the main interface between regulators and industry to agree on topics requiring further scientific discussion.
-
List item
Agenda – Nitrosamine Implementation Oversight Group (NIOG) – fifth meeting with pharmaceutical industry (PDF/126.16 KB) (new)
First published: 05/09/2023
EMA/INS/GMP/208026/2023 -
List item
Presentation - Nitrosamine Implementation Oversight Group (NIOG) – fifth meeting with pharmaceutical industry (PDF/866.76 KB) (new)
First published: 05/09/2023 -
List item
Highlights from the 5th meeting of the Nitrosamine Implementation Oversight Group (NIOG) industry partners (IP) (PDF/72.4 KB) (new)
First published: 05/09/2023
EMA/353298/2023